Published in Br J Urol on August 01, 1978
Viability of exfoliated colorectal carcinoma cells. Br J Surg (1984) 3.11
Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) (1981) 2.84
Joint hypermobility leading to osteoarthrosis and chondrocalcinosis. Ann Rheum Dis (1978) 2.44
The natural history of untreated "prostatism". Br J Urol (1981) 2.22
Magnetic resonance imaging in the identification of an otherwise undetectable upper pole moiety. Br J Urol (1993) 2.04
Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest (1991) 2.03
Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Q J Med (1976) 1.90
Urinary incontinence: prevalence and needs. Br J Urol (1979) 1.75
Pyridostigmine metabolism in man. Clin Pharmacol Ther (1972) 1.74
Biology of serum amyloid P component. Ann N Y Acad Sci (1982) 1.65
Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease. J R Soc Med (1984) 1.60
Injuries to the urethra. Br J Urol (1968) 1.55
Synovitis in polymyalgia rheumatica. Rheumatol Rehabil (1975) 1.54
Identification of a novel proline-directed serine/threonine protein kinase in rat pheochromocytoma. J Biol Chem (1989) 1.54
The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol (1979) 1.50
Prostatectomy in the over 80-year-old. Br J Urol (1989) 1.46
Disinfection of cystoscopes by subatmospheric steam and steam and formaldehyde at 80 degrees C. Br Med J (1971) 1.44
The Bristol Bladder Tumour Registry. Br J Urol (1969) 1.42
Educational benefits of audit. BMJ (1991) 1.40
Spacers and holding chambers: not the last word, we hope. Arch Dis Child (2001) 1.40
Proliferative and metastatic potential of exfoliated colorectal cancer cells. J Natl Cancer Inst (1986) 1.39
Optical criteria of urological endoscopes. Proc R Soc Med (1974) 1.39
Long-term follow-up of transvaginal urethral closure and suprapubic cystostomy for urinary incontinence in women with multiple sclerosis. Br J Urol (1994) 1.39
Observation of an antimatter hypernucleus. Science (2010) 1.38
Metabolism of [14C]-neostigmine in the rat. Br J Pharmacol Chemother (1965) 1.38
Partial extraction of double-J stent during nephrostomy tube removal and its prevention. Br J Urol (1991) 1.37
The actions of prostaglandins on the smooth muscle of the human urinary tract in vitro. Br J Urol (1975) 1.37
Distension of the bladder leading to vascular compression and massive oedema. Br J Urol (1968) 1.36
Coming to terms with advanced breast cancer: black women's narratives from eastern North Carolina. Soc Sci Med (1994) 1.30
Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol (1981) 1.25
Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med (1982) 1.24
The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost (1995) 1.23
Acute urinary retention--a urodynamic assessment. Br J Urol (1984) 1.20
The viability of human spleen cells after cooling in vitro. Br J Surg (1966) 1.19
Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol (1997) 1.18
The use of immunized pig lymph-node cells in the treatment of patients with advanced malignant disease. Br J Surg (1973) 1.17
Observations on the changing behaviour of AKR mouse lymphomas serially transplanted in the strain of origin. Immunology (1968) 1.17
Retracted Now you see it, now you don't: explicit versus implicit measures of the personal/group discrimination discrepancy. Psychol Sci (2000) 1.14
Idiopathic bladder instability treated by biofeedback. Br J Urol (1978) 1.14
The disinfection of urological endoscopes. Br J Urol (1975) 1.13
Trauma to the urethra. Injury (1975) 1.11
Microtransducer urethral profile methodology: variations caused by transducer orientation. J Urol (1983) 1.11
Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans. J Natl Cancer Inst (1985) 1.10
Carcinoma of the renal pelvis: a review of 43 cases. Br J Urol (1973) 1.10
Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation (2000) 1.10
Excretion and metabolism of [14C]-pyridostigmine in the rat. Br J Pharmacol Chemother (1966) 1.09
Trauma to the urinary tract. Br Med J (1971) 1.08
Method for demonstrating the chromosomes in adult human spleen cells. Nature (1965) 1.08
Long-term catheterization of the bladder: prevalence and morbidity. Br J Urol (1996) 1.06
Revised internal volumes of cascade impactors for those provided by mitchell and nagel. J Aerosol Med (2005) 1.05
An in vivo test for the immunocompetence of human lymphocytes. Transplantation (1973) 1.04
Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells. Br J Cancer (1981) 1.03
Ten years' experience of an amyloid clinic--a clinicopathological survey. Q J Med (1985) 1.02
Management of chronic urinary retention. Br Med J (Clin Res Ed) (1984) 1.01
Carcinoma of the ureter--a review of 54 cases. Br J Urol (1973) 1.01
Inhibition of banana polyphenoloxidase by 2-mercaptobenzothiazole. Science (1967) 1.01
The management of female incontinence by suprapubic catheterisation, with or without urethral closure. Br J Urol (1983) 1.00
Injuries to the upper urinary tract. Postgrad Med J (1967) 0.99
Further observations on the growth of mouse mammary carcinomata in the strain of origin. Attempts to transfer adoptive immunity against the tumour, to isogenic hosts, with spleen cells from tumour-bearing mice. Br J Cancer (1966) 0.98
Letter: Pre-eclampsia and the kidney. Br Med J (1974) 0.98
A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors. Cancer (1988) 0.98
Phosphorylation of synapsin I at a novel site by proline-directed protein kinase. J Biol Chem (1990) 0.98
Renal carcinoma in a cadaver kidney graft donor. Br Med J (1975) 0.98
Excretion and metabolism of oral 14-C neostigmine in the rat. Biochem Pharmacol (1966) 0.97
Nonlinear dynamic transfer characteristics of cells in the peripheral visual pathway of flies. I. The retinula cells. Biol Cybern (1975) 0.97
The excretion and metabolism of oral 14C-pyridostigmine in the rat. Br J Pharmacol (1968) 0.96
Clinical trial of gestronol hexanoate (SH582) in benign prostatic hypertrophy. Proc R Soc Med (1972) 0.96
Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q J Med (1979) 0.96
Drug-induced neonatal myasthenia. J Obstet Gynaecol Br Commonw (1969) 0.96
Strange baryon resonance production in sqrt s NN=200 GeV p+p and Au+Au collisions. Phys Rev Lett (2006) 0.96
Endorphins--a role in lower urinary tract function? The effect of opioid blockade on the detrusor and urethral sphincter mechanisms. Br J Urol (1982) 0.96
Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol (1997) 0.95
Systemic nodular panniculitis with cardiac involvement. J Clin Pathol (1974) 0.95
Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model. Am J Clin Pathol (1998) 0.94
Transurethral resection. Br Med J (1970) 0.94
Lack of correlation of synovial histology with joint damage in rheumatoid arthritis. Ann Rheum Dis (1975) 0.94
IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer (2000) 0.93
Lymphocyte reactivity in patients with carcinoma of the breast and large bowel. Br J Cancer (1975) 0.93
Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. Phys Rev Lett (2003) 0.93
[Spectral sensitivity of the complex eye of Musca. (Determination from measurements of the optomotor reaction)]. Kybernetik (1971) 0.92
Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. Br J Urol (1987) 0.92
Immunologically competent cells in the treatment of malignant disease. Lancet (1968) 0.92
Seminal vesicle tumours. J R Soc Med (1978) 0.92
Influence of mitochondria on phospholipid synthesis in preparations from rat liver. Biochem J (1973) 0.92
Identification of the poor risk patient with "prostatism" and detrusor failure. Br J Urol (1986) 0.92
Prostatectomy or conservative management in the treatment of benign prostatic hypertrophy? Br J Urol (1988) 0.92
High-dose intravenous estrogen therapy in advanced prostatic carcinoma. Use of serum prostate-specific antigen to monitor response. Urology (1989) 0.92
Evidence from d+Au measurements for final-state suppression of high-p(T) hadrons in Au+Au collisions at RHIC. Phys Rev Lett (2003) 0.92
Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus. Clin Immunol (2001) 0.91
Effects of temperature variation on suicide in five U.S. counties, 1991-2001. Int J Biometeorol (2007) 0.91
Further observations on whether host immunodepression is associated with tumour growth in mice. Br J Cancer (1971) 0.91
Early observations of the effect of extracorporeal shockwave lithotripsy on blood pressure: a prospective randomized control clinical trial. BJU Int (2000) 0.91
The identification of patients at risk from acute retention. Br J Urol (1980) 0.90
Tumour immunology. Br J Surg (1974) 0.90
Vesico-ureteric reflux in man. Br J Surg (1966) 0.90
Microangiopathy of brain, retina, and inner ear. J Neuroophthalmol (1995) 0.89
Prevalence of T cell receptor zeta chain deficiency in systemic lupus erythematosus. Lupus (2003) 0.89
Intravascular complications of transurethral resection of the prostate. Br J Urol (1982) 0.88
Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Mult Scler (2012) 0.88